Co-Authors
This is a "connection" page, showing publications co-authored by Olivier Schwartz and Isabelle Staropoli.
Connection Strength
0.942
-
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 08; 596(7871):276-280.
Score: 0.239
-
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021 05; 27(5):917-924.
Score: 0.234
-
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 09 17; 224(6):983-988.
Score: 0.061
-
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Sci Adv. 2021 08; 7(34).
Score: 0.060
-
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual. Open Forum Infect Dis. 2021 Aug; 8(8):ofab369.
Score: 0.060
-
Characteristics Associated with Olfactory and Taste Disorders in COVID-19. Neuroepidemiology. 2021; 55(5):381-386.
Score: 0.060
-
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep Med. 2021 05 18; 2(5):100275.
Score: 0.059
-
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro Surveill. 2021 04; 26(15).
Score: 0.059
-
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
Score: 0.056
-
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine. 2020 Sep; 59:102915.
Score: 0.056